Drug Shortage Report for ENGERIX-B
| Report ID | 105174 |
| Drug Identification Number | 02487039 |
| Brand name | ENGERIX-B |
| Common or Proper name | Hepatitis B vaccine (recombinant) |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPATITIS B SURFACE ANTIGEN |
| Strength(s) | 20MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1's (prefilled syringe / seringue préremplie) |
| ATC code | J07BC |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-02-03 |
| Estimated end date | 2020-03-27 |
| Actual end date | 2020-03-24 |
| Shortage status | Resolved |
| Updated date | 2020-03-25 |
| Company comments | Inventory on allocation to support demand in private market. Supply available for public programs. |
| Health Canada comments | |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.